Xenex

Market position

Xenex presents itself as a specialist in whole-room UV microbial reduction for healthcare, anchored on claims of being the first and only FDA-authorized broad spectrum UV robot in that category and the only UVC technology authorized for healthcare use across North America following Health Canada registration of LightStrike6.

Xenex differentiates on its patented pulsed xenon UV technology and on regulatory authorizations, stating it offers the first and only FDA-authorized broad spectrum UV robot for whole room microbial reduction and, with Health Canada registration of LightStrike6, the only UVC technology authorized for healthcare use across North America. Testimonial material references a facility switching from mercury UV to Xenex LightStrike robots. The company also stresses evidence-based scientific validation of its claims and the depth of its service, training and data support.

Technology

The core technology is a patented pulsed xenon ultraviolet (PXUV) system used in the LightStrike Germ-Zapping Robot for whole-room microbial reduction, described as broad spectrum UV and contrasted with mercury UV systems. Product generations include LightStrike PXUV4, LightStrike+ (models MXSUV1-FT and MXSUV1-SL) and LightStrike6 (models LSMUV6-FT and LSMUV6-SL). Supporting technology includes the Deactivate handheld LED unit and TrackMate, a digital tracking system for disinfection activity.

Go-to-market

Xenex sells directly to healthcare facilities and infection prevention programs, supported by customer success stories, clinician testimonials, product demonstrations ("Watch Demo"), toll-free sales and customer service lines, a client login portal, and dedicated government accounts and procurement options. Sales are accompanied by training, workflow consulting and service plans.

Primary customers are healthcare facilities and their infection prevention, infection control and quality teams, including hospital surgical suites; the company also addresses hospitality and transportation segments and serves government accounts.

Geography

Xenex is headquartered at 1074 Arion Circle, Suite 116, San Antonio, Texas, USA, and maintains separate United States and international website channels along with an international phone line with a UK dialing code (+44). Its regulatory footprint spans the United States (FDA authorization) and Canada (Health Canada registration of LightStrike6), and the company describes collaboration with clinicians and scientific experts around the world.

History

The company was co-founded in 2008 by Mark (Tuck) Stibich and Julie Stachowiak, who had met as doctoral students at Johns Hopkins University. It operates as Xenex Disinfection Services Inc. from San Antonio, Texas, and has developed successive generations of its pulsed xenon UV robots, including the LightStrike PXUV4, LightStrike+ (MXSUV1-FT and MXSUV1-SL) and LightStrike6 (LSMUV6-FT/LSMUV6-SL). Xenex has announced Health Canada registration for the LightStrike6 UV robot, which it describes as the first and only UVC technology authorized for healthcare use across North America.